Article

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

2023-07-19

Abstract excerpt

<title>Abstract</title> <p>Background Identifying response markers is highly needed to guide the treatment strategy in patients with metastatic melanoma. Methods A retrospective study was carried out in patients with unresectable/metastatic melanoma (stage IIIb–IV), treated with anti-PD-1 in the first line setting, to better explore the role and the timing of neutrophil/lymphocyte ratio (NLR) as potential bioma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0f028744-5882-548f-8086-ecc328645d1b
DOI: 10.21203/rs.3.rs-3163713/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapyDOI 10.21203/rs.3.rs-3163713/v1Read

NLRP3 is a Novel Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma and Skin Cutaneous MelanomaSemantic proximity Read

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanomaSemantic proximity Read

Immunological and clinical immunotherapy implications of NLRP3 mutations in melanoma.Semantic proximity Read

Clinical Correlation of CD39 Expression on Killer T Cells in peripheral blood in Cervical Squamous Cell CarcinomaSemantic proximity Read

The Role of NLRP3 in The Prognosis and Immune Infiltrates of Skin Cutaneous Melanoma (SKCM)Semantic proximity Read

Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal CancerSemantic proximity Read

Systemic Inflammatory Indices as Accessible Biomarkers for Intracranial Outcome and Prognosis in Driver Gene-Negative NSCLC with Brain Metastases Treated with First-Line ChemoimmunotherapySemantic proximity Read

Prognostic value of the neutrophil-to-lymphocyte ratio and primary tumor location in patients with EGFR-mutated metastatic non-small cell lung cancer treated with TKIsNote: We found that we got a wrong results in the previous article. So, we checked our collected database and calculated again and corrected now.Semantic proximity Read

Chemokines in the melanoma metastasis biomarkers portrait.Semantic proximity Read

NLRP13 mutation as a predictive indicator for immune checkpoint inhibitor efficacy in melanoma and NSCLCSemantic proximity Read

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapySemantic proximity Read

The profile and prognostic value of circulating lymphocyte subsets in metastatic colon cancer.Semantic proximity Read